2004-2005 President Paul W. Ladenson, M.D. Baltimore, Maryland Secretary Gregory A. Brent, M.D. Los…
Read More
AACE, TES, and ATA Joint Position Statement on the Use and Interchangeability of Thyroxine Products…
Thyroid Experts Warn of Clinically Important Differences in Potency of FDA-Approved Levothyroxine Products Generic bioequivalence…
Thyroid Experts Speak Out Against the FDA’s Decision to Approve Generic Levothyroxine Preparations FDA approval…
ATA, TES, and AACE express disappointment and concern for the health of millions of thyroid…
ATA and Endocrine Sister Societies urge FDA to consider expert opinion and the health of…
ATA, AACE and TES respond to FDA postponement of workshop March 19, 2004 Steven Galson,…
FDA Bioequivalence Workshop Plans continue with ATA, Endocrine Society and AACE leaders 2003-2004 President Clark…
Draft Levothyroxine Workshop Agenda Download Agenda (PDF File, 108 KB) See related articles on Bioequivalence…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.